“All the Feels: An ADHD Guide to Emotional Dysregulation and Rejection Sensitive Dysphoria” [podcast episode #259]
People with ADHD feel emotions more intensely, more frequently, and more suddenly. In fact, one third of adults with ADHD name this as the most impairing aspect of the condition. Tune in to learn more about out-of-control emotions from William W. Dodson, M.D.
Listen to “All the Feels: An ADHD Guide to Emotional Dysregulation and Rejection Sensitive Dysphoria” with William W. Dodson, M.D.
Click here to view the original webinar broadcast and accompanying slides.
People with ADHD feel emotions more intensely, more frequently, and more suddenly. For many, emotional dysregulation is one of the most challenging core symptoms of ADHD to manage. In fact, one third of adults with ADHD say the inability to manage their emotions is the most impairing aspect of their ADHD, adversely affecting work performance and personal relationships.
Among the biggest emotional challenges facing adults with ADHD is Rejection Sensitive Dysphoria, an extreme sensitivity to criticism and judgment that seems to exist only in those diagnosed with the disorder. The good news is that certain ADHD medications can relieve RSD for about half of people diagnosed with it.
- “Excellent, excellent, excellent! After attending this webinar, I immediately wanted to listen to the replay!”
- “Dr. Dodson, I cannot thank you enough. The impact of meeting someone who understands, at age 59, is profound. All best wishes.”
- “This was amazing. I feel so affirmed, and inspired to seek treatment. Thank you!”
- “Dr. Dodson is an excellent resource and I’ve learned from every webinar he’s given.”
Related recommended resources:
- Free Download: ADHD and Intense Emotions
- [Self-Test] Sensory Processing Disorder (SPD) in Adults
- [Self-Test] Could You Have Rejection Sensitive Dysphoria?
- ADHD, Women, and the Danger of Emotional Withdrawal
William W. Dodson, M.D., is a member of the ADDitude ADHD Medical Review Panel.
This ADHD Experts webinar was first broadcast live on May 23, 2019. ADDitude thanks our sponsors for supporting our webinars. Sponsorship has no influence on speaker selection or webinar content.
Note on audio quality: This podcast is a recording of a webinar series. The audio has been captured from live conversations (sometimes over a telephone), not recorded in a studio. Register to participate in the live webinars at: additude.com/webinars/
The sponsor of this week’s ADDitude webinar is….
OmegaBrite: OmegaBrite 70/10 MD is a proprietary high concentrate Omega-3 formulation, developed by Dr. Carol Locke while on faculty at Harvard Medical School. Clinically demonstrated to reduce anxiety by 20% in healthy medical students in an NIH funded double-blind placebo-controlled clinical trial, and to reduce inflammatory cytokines IL-6 by 14%. Order now exclusively at omegabrite.com
ADDitude thanks our sponsors for supporting our webinars. Sponsorship has no influence on speaker selection or webinar content.
Updated on July 15, 2021